University of California San Francisco
Give to UCSF
The cause of the pancreatic inflammation plaguing a rural California family has been a medical mystery since it was first described 51 years ago. Now genetic sleuth-work by researchers from UC San Francisco and the University of Chicago has solved the mystery: pointing to a novel gene mutation as the cause of the family’s inherited pancreatitis.
An algorithm developed by scientists at UC San Francisco and UC Berkeley did better than two out of four expert radiologists at finding tiny brain hemorrhages in head scans—an advance that one day may help doctors treat patients with TBI, strokes and aneurysms.
The National Institutes of Health has awarded a five-year, multi-investigator research grant expected to total more than $63 million to Mayo Clinic and UC San Francisco, to advance treatments for frontotemporal lobar degeneration.
UCSF is launching a new center to accelerate the application of AI technology to radiology.
Tens of thousands of Americans suffer pneumothorax each year, a potentially life-threatening condition that is sometimes overlooked in busy emergency rooms.
Researchers devised “smart” cells that behave like tiny autonomous robots which may be used to detect damage and disease, and deliver help at just the right time and in just the right amount.
Pioneering test called metagenomic next-generation sequencing shown to identify infections better than any standard clinical method.
A two-week course of an experimental immunotherapy called teplizumab dramatically reduced type 1 diabetes (T1D) diagnosis rates in people at high risk for the disease, according to newly published
The intervention, an app called MediTrain, uses a closed-loop algorithm that tailors the length of meditation sessions to the abilities of the participants.
The UCSF study examined whether a mobile phone physical activity app combined with brief, in-person counseling increased and maintained levels of physical activity
A research team led by scientists at UC San Francisco and the Chan Zuckerberg Biohub has developed a new CRISPR-based diagnostic tool, dubbed FLASH, that can rapidly identify any drug-resistant
The technology could one day restore the voices of people who have lost the ability to speak due to paralysis and other forms of neurological damage.
